A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 3,021 shares of ZTS stock, worth $493,359. This represents 0.31% of its overall portfolio holdings.

Number of Shares
3,021
Previous 2,963 1.96%
Holding current value
$493,359
Previous $513,000 15.01%
% of portfolio
0.31%
Previous 0.28%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$172.58 - $196.48 $10,009 - $11,395
58 Added 1.96%
3,021 $590,000
Q2 2024

Jul 17, 2024

SELL
$145.54 - $178.83 $45,699 - $56,152
-314 Reduced 9.58%
2,963 $513,000
Q1 2024

Apr 23, 2024

BUY
$165.67 - $199.94 $1,325 - $1,599
8 Added 0.24%
3,277 $554,000
Q4 2023

Jan 26, 2024

BUY
$151.44 - $200.09 $605 - $800
4 Added 0.12%
3,269 $645,000
Q3 2023

Oct 13, 2023

SELL
$167.14 - $192.77 $5,515 - $6,361
-33 Reduced 1.0%
3,265 $568,000
Q2 2023

Jul 14, 2023

BUY
$160.94 - $186.23 $9,334 - $10,801
58 Added 1.79%
3,298 $567,000
Q1 2023

Apr 24, 2023

SELL
$145.48 - $175.02 $9,747 - $11,726
-67 Reduced 2.03%
3,240 $539,000
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $36,325 - $43,619
-277 Reduced 7.73%
3,307 $484,000
Q3 2022

Oct 24, 2022

BUY
$148.29 - $182.55 $45,525 - $56,042
307 Added 9.37%
3,584 $532,000
Q2 2022

Jul 20, 2022

SELL
$155.97 - $200.09 $3,587 - $4,602
-23 Reduced 0.7%
3,277 $563,000
Q1 2022

Apr 22, 2022

BUY
$181.39 - $234.03 $140,214 - $180,905
773 Added 30.59%
3,300 $622,000
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $8,134 - $10,375
42 Added 1.69%
2,527 $617,000
Q3 2021

Nov 01, 2021

BUY
$189.29 - $209.69 $46,376 - $51,374
245 Added 10.94%
2,485 $482,000
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $349,216 - $421,097
2,240 New
2,240 $417,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cherry Creek Investment Advisors, Inc. Portfolio

Follow Cherry Creek Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.